Search

Showing total 14,831 results

Search Constraints

Start Over You searched for: Search Limiters Academic (Peer-Reviewed) Journals Remove constraint Search Limiters: Academic (Peer-Reviewed) Journals Topic therapeutics Remove constraint Topic: therapeutics Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years Publisher wiley-blackwell Remove constraint Publisher: wiley-blackwell
14,831 results

Search Results

151. Which acne treatment has the best influence on health‐related quality of life? Literature review by the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes.

152. What is the best treatment for a child with an acute tear of the anterior cruciate ligament?

153. What can the treatment of Parkinson's disease learn from dementia care; applying a bio-psycho-social approach to Parkinson's disease.

154. "We live in the moment"—Experiences of people with Intellectual Disabilities and Clinicians of Computer‐Assisted Mindfulness and Relaxation.

155. Contribution of protein A step towards cost of goods for continuous production of monoclonal antibody therapeutics.

156. Effect of CD38 on B‐cell function and its role in the diagnosis and treatment of B‐cell‐related diseases.

157. Introducing dental hygienists in general practice to research - an in-practice evaluation programme in the United Kingdom.

158. A systematic review of outcome reporting in laser treatments for dermatological diseases.

159. Treatments in Aicardi-Goutières syndrome.

160. Congenital adrenal hyperplasia and violation of newborn screening procedures.

161. Huntington Study Group's Neuropsychology Working Group: Implementing Non‐Motor Diagnostic Criteria.

162. Pilot feasibility and acceptability study evaluating use of group CBT‐I in improving sleep and fatigue in older adults.

163. Converting a drug from off‐label to on‐label use: Government subsidies and patient welfare.

164. Collaborative leadership in transplantation: Blending clinical, business, and regulatory roles.

165. Preclinical development and characterization of a human plasma‐derived high‐purity factor X concentrate for therapeutic use.

166. 'Doing family' in adversity: Findings from a qualitative study exploring family practices in alternative care settings in Thailand.

167. Pneumatosis intestinalis after thoracic organ transplantation in children: A case series and review of the literature.

168. SlowMo therapy, a new digital blended therapy for fear of harm from others: An account of therapy personalisation within a targeted intervention.

169. Advances in the Stimuli‐Responsive Injectable Hydrogel for Controlled Release of Drugs.

170. Post‐COVID‐19 Myoclonus‐Ataxia Syndrome—Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?

171. On-demand treatment in persons with severe haemophilia.

172. A Systematic Review of Outcome Measurements and Quality of Studies Evaluating Fixed Tooth-Supported Restorations.

173. Craving Interpretation: A Case of Somatic Countertransference.

174. Socio-behavioural aspects in the prevention and control of dental caries and periodontal diseases at an individual and population level.

175. Crohn's disease should be considered in children with inflammatory oral lesions.

176. Clinical study of Gene‐Eden‐VIR/Novirin in genital herpes: suppressive treatment safely decreases the duration of outbreaks in both severe and mild cases.

177. Interventions for managing weight change following paediatric acquired brain injury: a systematic review.

178. 34.5: Four‐mask process Architecture using NH3 plasma treatment technology for Image Sticking Improvement in 32‐inch TV Product.

179. Periodontitis Is Characterized by an Immuno-Inflammatory Host-Mediated Destruction of Bone and Connective Tissues That Support the Teeth.

180. Bioinformatics approach used in undergraduate research to predict siRNA as ZIKV therapeutics.

181. Decision‐making experiences of young adults with long‐term conditions.

182. Improvement of Skin Barrier Dysfunction by Phenolic‐containing Extracts of Lycium barbarum via Nrf2/HO‐1 Regulation.

183. Speech and language therapy service provision in spinal injury units compared to major trauma centres in England: Are services matched?

184. When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?

185. II. A Brief Introduction to the thought of Armando B. Ferrari.

186. Are bruxism and the bite causally related?

187. Intervention Research in Couple and Family Therapy: A Methodological and Substantive Review and an Introduction to the Special Issue.

188. Identification, Classification, and Treatment of Reading and Language Disabilities in Spanish‐Speaking EL Students: Introduction to the Special Issue.

189. TOOLS FOR RE‐RANDOMIZATION.

190. Team orienteering with uncertain rewards and service times with an application to phlebotomist intrahospital routing.

191. Therapeutic approaches to pyogenic granuloma: an updated review.

192. Phase II trial to investigate efficacy and safety of bendamustine, dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib.

193. Alcohol and Women: A Brief Overview.

194. 'What's cooking?' A comparison of an activity‐oriented and a table‐top programme of therapy on the language performance of people with aphasia.

195. A review of the frequency and nature of adaptations to cognitive behavioural therapy for adults with Intellectual Disabilities.

196. The effect of antiseptic oral sprays on dental plaque and gingival inflammation: A systematic review and meta‐analysis.

197. Iatrogenic cerebral gas embolism-A systematic review of case reports.

198. Online monitoring of flu in Belgium.

199. Effects of lifestyle change interventions for people with intellectual disabilities: Systematic review and meta‐analysis of randomized controlled trials.

200. Dyadic Developmental Psychotherapy: an effective and evidence-based treatment – comments in response to Mercer and Pignotti.